FDA Guidance Documents·· 原文未提供具体时分
Submissions for Postapproval Modifications to a Combination Product Approved Under a BLA, NDA, or PMA: Draft Guidance for Industry and FDA Staff
Submissions for Postapproval Modifications to a Combination Product Approved Under a BLA, NDA, or PMA: Draft Guidance for Industry and FDA Staff
AI 导读
FDA 官方历史目录记录；Draft guidance；发布日期：2013-01-18。官方主题：Combination Products。请通过官方原文与附件查阅文件。
来源：FDA Guidance Documents · fda.gov